XK
BHVN

Xact Kapitalforvaltning’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Xact Kapitalforvaltning’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$248K Hold
7,300
– – 0.01% 1114
2019
Q4 		$397K Hold
7,300
– – 0.01% 1109
2019
Q3 		$305K Hold
7,300
– – 0.01% 1192
2019
Q2 		$320K Buy
+7,300
New +$412K 0.01% 1187

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Xact Kapitalforvaltning's BHVN Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) position steady in Q1 2020 at 7,300 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #1114.

Xact Kapitalforvaltning first reported a position in BHVN in Q2 2019 and has held it in 4 quarters since. The position peaked at $397K in Q4 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

  • Xact Kapitalforvaltning held 7,300 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $248K as of Q1 2020.
  • Xact Kapitalforvaltning left its Biohaven Pharmaceutical Holding Company Ltd. share count unchanged in Q1 2020.
  • Biohaven Pharmaceutical Holding Company Ltd. made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1114 holding.
  • Xact Kapitalforvaltning first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and has held it in 4 quarters since.
  • Xact Kapitalforvaltning's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $397K in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.